Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 110226 |
Drug Identification Number | 02439131 |
Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
Strength(s) | 36G 4.5G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1 VIAL |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-03-17 |
Estimated end date | Unknown |
Actual end date | 2020-04-07 |
Shortage status | Resolved |
Updated date | 2020-04-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-31 | English | Compare |
v2 | 2020-03-31 | French | Compare |
v3 | 2020-04-07 | English | Compare |
v4 | 2020-04-07 | French | Compare |
Showing 1 to 4 of 4